Dr. Reddy's Laboratories Ltd. ADS (RDY) News Nov 18, 2014,

New Post Public Reply Private Reply Replies (0) Message Board
Savant
Dr. Reddy's Laboratories Ltd. ADS (RDY) News Nov 18, 2014, 10:01 a.m.
MarketWatch News on RDY
Top three Indian stocks to buy (and hold) 5:16 a.m. Oct. 17, 2014 - Henry To
India's drug makers move toward automation 7:26 p.m. June 5, 2014 - MarketWatch.com
The stock, currency, country and commodity for 2014 12:02 a.m. Jan. 7, 2014 - nigam arora
3 big reasons to invest in India 11:02 p.m. Sept. 2, 2013 - Nigam Arora
Dr Reddy's starts U.S. sales of baldness generic 5:18 a.m. Jan. 3, 2013 - MarketWatch.com
26 ways to profit from ‘Obamacare’ 6:01 a.m. Nov. 8, 2012 - The Trading Deck
Dr Reddy's bids 27.4 million euros for OctoPlus 11:49 p.m. Oct. 21, 2012 - MarketWatch.com
Dr Reddy's: US FDA lifts import ban on Mexico site 9:06 a.m. July 27, 2012 - MarketWatch.com
How to profit from the health-care ruling 12:55 p.m. June 28, 2012 - The Trading Deck
Dr Reddy's, Merck Serono to develop biotech drugs 2:45 a.m. June 6, 2012 - MarketWatch.com
Genpact to provide finance services to Dr Reddy's 3:00 a.m. May 22, 2012 - MarketWatch.com
India’s pharma, consumer stocks shine 11:18 a.m. May 18, 2012 - Nick Godt
Dr Reddy's: FDA to inspect Mexico plant in March 2:51 a.m. March 20, 2012 - MarketWatch.com
Dr Reddy's Laboratories net profit soars 88% 6:43 a.m. Feb. 3, 2012 - MarketWatch.com
Dr Reddy's 2nd-quarter net exceeds estimates 5:20 a.m. Oct. 25, 2011 - MarketWatch.com
Dr. Reddy's blood-cholesterol drug advances 9:16 a.m. Sept. 2, 2011 - MarketWatch.com
Sun Pharma looks past generics as challenges loom 4:48 a.m. July 15, 2011 - V. Phani Kumar
Dr Reddy's gets U.S. OK to sell generic Arixtra 12:01 a.m. July 13, 2011 - MarketWatch.com
FDA bans imports from Dr. Reddy Mexico plant 4:09 p.m. July 6, 2011 - MarketWatch.com
Seven demographic trends to buy now 12:01 a.m. March 10, 2011 - Jeff Reeves
Loading more headlines...
Advertisement
Other News on RDY
Sucampo-Takeda Sue Dr. Reddy's for Amitiza Patent Violation - Analyst Blog 4:30 p.m. Nov. 13, 2014 - Zacks.com
3 Drugs Stocks Pushing The Industry Higher 12:06 p.m. Nov. 7, 2014 - TheStreet.com
Today Dr Reddy Laboratories (RDY) Hits New Lifetime High 9:46 a.m. Nov. 7, 2014 - TheStreet.com
Dr. Reddy's cleared for generic Valcyte 7:34 a.m. Nov. 7, 2014 - Seeking Alpha
Dr. Reddy's Laboratories Ltd. (RDY): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 7, 2014 - Zacks.com
Hottest Healthcare Stocks Now – RDY INCY MWIV PRGO 6:30 a.m. Nov. 7, 2014 - InvestorPlace.com
Dr. Reddy's (RDY) Q2 Earnings Fall, Revenues Up Y/Y - Analyst Blog 5:20 p.m. Oct. 30, 2014 - Zacks.com
Trade of the Day: Dr. Reddy’s Laboratories (RDY) 3:57 a.m. Oct. 30, 2014 - InvestorPlace.com
Dr. Reddy's Laboratories (RDY) Q2 2015 Results - Earnings Call Transcript 1:50 a.m. Oct. 30, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – BABY LUX PDLI ABBV 2:00 p.m. Oct. 22, 2014 - InvestorPlace.com
Sucampo Enters into Settlement Agreement for Amitiza - Analyst Blog 5:50 p.m. Oct. 13, 2014 - Zacks.com
Drugmaker M&A Goes On, With Or Without Tax Inversions 4:37 p.m. Oct. 10, 2014 - Investors Business Daily
Generics Firms Step Up Their Game In Branded Drugs 5:08 p.m. Oct. 6, 2014 - Investors Business Daily
Here’s What to Expect From Australian Biotechs 1:30 a.m. Oct. 6, 2014 - InvestorPlace.com
Dr. Reddy's (RDY) Generic Xopenex Launched in the US - Analyst Blog 6:19 p.m. Sept. 25, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – ENDP RDY WX ACHN 1:30 p.m. Sept. 25, 2014 - InvestorPlace.com
New Lifetime High For Dr Reddy Laboratories (RDY) 9:47 a.m. Sept. 24, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – RDY SNN CBPO PTCT 8:15 a.m. Sept. 18, 2014 - InvestorPlace.com
Trade-Ideas: Dr Reddy Laboratories (RDY) Is Today's New Lifetime High Stock 9:45 a.m. Sept. 17, 2014 - TheStreet.com
Novartis heart failure drug candidate beats enalapril 12:05 p.m. Aug. 30, 2014 - Seeking Alpha
Loading more headlines...
Press Releases on RDY
Dr. Reddy’s Announces the Launch of Sirolimus Tablets, 1 mg and 2 mg 12:24 p.m. Oct. 28, 2014 - BusinessWire - BZX
Dr. Reddy's to Release Q2 FY15 Results on October 29, 2014 4:38 a.m. Oct. 17, 2014 - BusinessWire - BZX
Dr. Reddy’s Announces the Launch of LEVALBUTEROL INHALATION SOLUTION, USP 2:27 a.m. Sept. 24, 2014 - BusinessWire - BZX
Dr. Reddy's to Release Q1 FY15 Results on July 30, 2014 2:51 a.m. July 23, 2014 - BusinessWire - BZX
Corporate Updates, Certifications, and Product Launches - Analyst Notes on Analogic, Masimo, Dr. Reddy's, BioSpecifics and Bio-Rad 5:00 a.m. July 2, 2014 - PR Newswire - PRF
Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F 2:28 a.m. June 27, 2014 - BusinessWire - BZX
Dr. Reddy’s Announces the Launch of Duloxetine Delayed-Release Capsules USP 2:27 a.m. June 27, 2014 - BusinessWire - BZX
Dr. Reddy’s announces the Launch of Paricalcitol Capsules 9:22 a.m. June 25, 2014 - BusinessWire - BZX
Pharma Stocks under Review -- Research on Mylan, Sanofi, Impax Laboratories, and Dr. Reddy's Laboratories 6:30 a.m. June 3, 2014 - PR Newswire - PRF
Milestone Payments, Clinical Trial Results, Technical Updates, and Earnings Results - Analyst Notes on Pharmacyclics, Isis, Novo Nordisk, Dr. Reddy's and Orexigen 4:10 a.m. May 29, 2014 - PR Newswire - PRF
Senior Level Changes at Dr. Reddy’s 2:59 a.m. May 14, 2014 - BusinessWire - BZX
Pre-market Equity Watch on the Health Care Sector -- Research on ArthroCare, HCA Holdings, Select Medical Holdings, and Dr Reddy's Laboratories 4:37 a.m. May 5, 2014 - PR Newswire - PRF
Dr. Reddy's to Release Q4 and Full Year FY14 Results on May 13, 2014 4:48 a.m. May 1, 2014 - BusinessWire - BZX
Dr. Reddy’s Announces the Launch of Fenofibrate Capsules, USP 43 mg and 130 mg 1:53 a.m. April 23, 2014 - BusinessWire - BZX
Dr. Reddy’s Announces the Launch of Eszopiclone Tablets C-IV 1:30 a.m. April 16, 2014 - BusinessWire - BZX
Product Launches, Acquisitions, Closed Offerings, Divestitures, and Financial Results - Analyst Notes on Dr. Reddy's, ICON, Endocyte, BioScrip, and DepoMed 7:00 a.m. April 7, 2014 - PR Newswire - PRF
Dr. Reddy’s Announces the Launch of Amlodipine Besylate and Atorvastatin Calcium Tablets 3:12 a.m. March 27, 2014 - BusinessWire - BZX
Dr. Reddy’s Announces the Launch of Moxifloxacin Hydrochloride Tablets 2:22 a.m. March 5, 2014 - BusinessWire - BZX
Dr. Reddy’s Announces the Launch of Sumatriptan Injection USP, Autoinjector System 12:44 a.m. Feb. 26, 2014 - BusinessWire - BZX
Dr. Reddy’s Q3 & 9 Months FY14 Financial Results 5:51 a.m. Feb. 11, 2014 - BusinessWire - BZX
Loading more headlines...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Auria, LSAS Team Up: Japan Space Frontier Beckons

Updated Category News Views 105

Pioneering Ventures in Japan's Space Race Watch out, folks—Auria and LSAS Tec have something cooking. One's a titan in space technology, and the other's a maestro in mission analysis. They're joining forces to tango in Japan's booming space market. If you're into the street-smart equity dance, this partnership ain't just chatter over coffee; it's a leap toward new...

Continue Reading
Linux Foundation Unveils the Global Fraud Alliance

Updated Category News Views 99

Who would have thought the tech wizards at the Linux Foundation would step up to tackle fraud on a global scale? That's what we've got with their latest play: the Open Financial Trust Alliance (OFTA). Launched at the Singapore FinTech Festival, they've got their sights on connecting the world's disconnected fraud fight. Think of it as a translator for the tangled mess of...

Continue Reading
Madrigal Pharmaceuticals Faces Legal Scrutiny Over Data

Updated Category News Views 152

Legal Storm Brews for Madrigal Pharmaceuticals Watch out, here comes another storm for Madrigal Pharmaceuticals, folks. This ain't no small drizzle either; it's a full-on legal monsoon, and it's soaked straight through the walls of their executive suite. We're talking a whistleblower sending alarm bells ringing about data fudging and some dodgy boardroom maneuvers—as if...

Continue Reading
Universal Haptics Protocol May Cut Integration Friction

Updated Category News Views 301

A controller rumbling at the wrong moment is a small annoyance, but the plumbing behind that rumble has been a stubborn mess for years. The Haptics Industry Forum's Universal Haptics Protocol 1.0, announced November 17, 2026, is an attempt to clean up that mess with a shared language between software and touch-feedback hardware. This is not the sort of release that sends...

Continue Reading
Azazie Tests Bridal Demand With Two East Coast Pop-Ups

Updated Category News Views 116

Wedding dresses are a miserable product to buy sight unseen, no matter how pretty the product photos look. That basic fact is why Azazie’s two East Coast pop-ups on November 21 and 22 deserve a closer look. This is not some grand retail rollout, and nobody should pretend a pair of short events rewrites the bridal market. But it is a practical test of where a...

Continue Reading
Iberostar's Grand Move: Opening in Zanzibar

Updated Category News Views 135

The Resort That Takes Your Breath Away Here we have Iberostar, boldly wading into the azure waters of the Indian Ocean, planting its flag on the sandy beaches of Zanzibar. This isn’t just another notch on the resort’s belt—it’s their first time setting up shop in East Africa, a move ripe with promise and adventure both. A Suite So Sweet 358 suites, mind you. Each...

Continue Reading
Stand Out For Good Makes a Bold Michigan Avenue Bet

Updated Category News Views 183

A six-floor retail commitment lands with a thud Stand Out For Good is taking on roughly 51,079 square feet at 669 North Michigan Avenue, and nobody should mistake that for a casual expansion. Six levels on Chicago's Magnificent Mile is a proper declaration of intent, especially in a retail district that has endured plenty of empty-window handwringing and big-brand churn....

Continue Reading
Clorox Boosts Payout With Steady $1.25 Dividend

Updated Category News Views 165

Quarterly Dividends: A Clorox Tradition It seems you can't talk about Clorox (NYSE: CLX) without mentioning its steadfast dedication to shareholders. Once again, this 113-year-old stalwart is back on the map with its juicy quarterly dividend—$1.25 per share, to be precise. That's scheduled to hit your account by February 12, 2027, if you're on the books by the end of...

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 114

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading
Legato Frames Put Tiny AI to a Real-World Hearing Test

Updated Category News Views 156

A hearing aid that never enters the ear is a deceptively brutal product challenge. It has to hear speech through a mess of restaurant clatter, traffic, wind and ordinary human commotion; it has to run all day; and, crucially, it cannot look like a medical concession somebody reluctantly straps on. Legato Frames are aiming right at that knot, with femtoAI providing the...

Continue Reading

Top 5 Most Recently Viewed Articles

US LBM Expands Reach with Strategic Milton Truss Acquisition

Updated Category News Views 423

US LBM Welcomes Milton Truss to Its Family US LBM, a leading distributor of specialty building materials, has made a significant move by acquiring Milton Truss, a well-respected manufacturer specializing in structural building components. This acquisition expands US LBM’s operational capabilities and strengthens its presence in the Southeast, particularly within the...

Continue Reading
US Residential Construction Market Shows Promising Growth Ahead

Updated Category News Views 332

The Future of the US Residential Construction Market The residential construction market in the United States is poised to experience significant growth, with estimates suggesting an increase of USD 242.9 million from 2025 to 2029. As household formation rates rise, there is an unmistakable trend towards building more residential units, coupled with an increasing emphasis...

Continue Reading
Orbital Amplifies Currency Reach with Banking Circle

Updated Category News Views 30

Unpacking Orbital's New Alliance with Banking Circle Today's chat's all about payments—specifically how Orbital's rolling out the red carpet with Banking Circle to ramp up their multi-currency payment interface. The company's stretching its limbs into the Nordics, Central Europe, Switzerland, and Australia. With a suit like this, Orbital's not just dropping coins into...

Continue Reading
Jorge Blanco's Achievement Acknowledged as 2025 CRE Tech Influencer

Updated Category News Views 466

Jorge Blanco Celebrated as a 2025 CRE Tech Influencer Altus Group Limited (TSX: AIF), a leading force in asset and fund intelligence for the commercial real estate sector, is excited to announce that its Chief Commercial Officer, Jorge Blanco, has received recognition as a 2025 CRE Technology Influencer. This accolade comes from a renowned publication dedicated to...

Continue Reading
Investor Concerns Rise for Unicycive Therapeutics (UNCY) Amid Investigation

Updated Category News Views 200

Investigating Securities Concerns at Unicycive Therapeutics In the fast-paced world of pharmaceuticals, investor sentiment can shift dramatically based on the health of the company and news that emerges. Currently, Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is facing scrutiny as Pomerantz LLP has initiated an investigation concerning potential claims on behalf of its...

Continue Reading